Importantly, results showed that the antigen–antibody reaction enhanced the stability of the anti-G250 NTNs and their binding to tumor cells, resulting in higher aggregation and retention of the anti-G250 NTNs in the G250-expressing xenografts at levels approximately tenfold those observed in non-G250-expressing xenografts. This evidence concerns the gene CA9 and neoplasm.